Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
269.27
-3.48 (-1.28%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Krystal Biotech Revenue
In the year 2025, Krystal Biotech had annual revenue of $389.13M with 33.94% growth. Krystal Biotech had revenue of $107.11M in the quarter ending December 31, 2025, with 17.52% growth.
Revenue (ttm)
$389.13M
Revenue Growth
+33.94%
P/S Ratio
20.37
Revenue / Employee
$1,319,085
Employees
295
Market Cap
7.93B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Halozyme Therapeutics | 1.40B |
| Bio-Techne | 1.22B |
| Axsome Therapeutics | 638.50M |
| ImmunityBio | 113.29M |
| Cytokinetics | 88.04M |
| Kymera Therapeutics | 39.21M |
| Arcellx | 22.29M |
| Praxis Precision Medicines | 7.46M |
KRYS News
- 7 days ago - Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026 - GlobeNewsWire
- 2 months ago - Krystal Biotech Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Krystal Biotech Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Krystal Biotech Announces Fourth Quarter and Full Year 2025 Financial and Operating Results - GlobeNewsWire
- 2 months ago - Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - GlobeNewsWire
- 3 months ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 3 months ago - Krystal Biotech Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 3 months ago - Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire